TickerFacts.

Bone Biologics Corp (BBLG): Shareholders' Equity

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-03-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$5.38M
As of 2025-12-31
$3.92M
As of 2026-06-30
-3.3%
3-year compound annual growth
$6.58M2007-10-31: -$9.7K2008-10-31: -$10.2K2009-10-31: -$20.5K2010-10-31: -$24.0K2011-10-31: -$29.0K2012-10-31: -$34.6K2013-10-31: -$39.8K2013-12-31: -$5.61M2014-12-31: -$3.70M2015-12-31: -$5.68M2016-03-31: -$3.23M2016-06-30: -$5.38M2016-09-30: -$6.96M2016-12-31: -$8.36M2017-03-31: -$7.85M2017-06-30: -$9.68M2017-09-30: -$10.18M2017-12-31: -$8.40M2018-12-31: -$8.60M2019-12-31: -$11.87M2020-12-31: -$13.69M2021-12-31: $6.58M2022-12-31: $5.95M2023-12-31: $2.91M2024-12-31: $3.48M2025-12-31: $5.38M$5.38M
2007-10-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$5.38M+54.4%2026-03-02, Balance as of period end
2024-12-31$3.48M+19.9%2026-03-02, Balance as of period end
2023-12-31$2.91M-51.1%2025-02-26, Balance as of period end
2022-12-31$5.95M-9.6%2024-02-21, Balance as of period end
2021-12-31$6.58Mn/m2023-03-30, Balance as of period end
2020-12-31-$13.69Mn/m2022-03-15, Balance as of period end
2019-12-31-$11.87Mn/m2021-04-15, Balance as of period end
2018-12-31-$8.60Mn/m2020-03-30, Balance as of period end
2017-12-31-$8.40Mn/a2019-03-29, Balance as of period end
2017-09-30-$10.18Mn/a2018-04-02, Balance as of period end
2017-06-30-$9.68Mn/a2018-04-02, Balance as of period end
2017-03-31-$7.85Mn/a2018-04-02, Balance as of period end
2016-12-31-$8.36Mn/a2018-04-02, Balance as of period end
2016-09-30-$6.96Mn/a2018-04-02, Balance as of period end
2016-06-30-$5.38Mn/a2018-04-02, Balance as of period end
2016-03-31-$3.23Mn/c2018-04-02, Balance as of period end
2015-12-31-$5.68Mn/m2017-03-30, Balance as of period end
2014-12-31-$3.70Mn/m2016-03-28, Balance as of period end
2013-12-31-$5.61Mn/a2015-03-31, Balance as of period end
2013-10-31-$39.8Kn/m2014-02-13, Balance as of period end
2012-10-31-$34.6Kn/m2014-02-13, Balance as of period end
2011-10-31-$29.0Kn/m2014-02-13, Balance as of period end
2010-10-31-$24.0Kn/m2014-02-13, Balance as of period end
2009-10-31-$20.5Kn/m2014-02-13, Balance as of period end
2008-10-31-$10.2Kn/m2014-02-13, Balance as of period end
2007-10-31-$9.7Kn/a2012-01-30, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Orthopedic, Prosthetic & Surgical Appliances & Supplies), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Bone Biologics Corp (BBLG)2025-12-31$5.38M+54.4%
NutriBand Inc. (NTRB)2026-01-31$6.68M+3.9%
Regentis Biomaterials Ltd. (RGNT)2025-12-31$4.74Mn/m
Milestone Scientific Inc. (MLSS)2025-12-31$2.81M-51.8%
Envoy Medical, Inc. (COCH)2025-12-31-$12.16Mn/m
CollPlant Biotechnologies Ltd (CLGN)2025-12-31$6.08M-54.8%
Safe Pro Group Inc. (SPAI)2025-12-31$17.72M+357.3%
Vicarious Surgical Inc. (RBOT)2025-12-31$9.84M-78.9%
LogicMark, Inc. (LGMK)2025-12-31$16.28M+56.8%

Compare BBLG, NTRB, RGNT, MLSS side by side · Screen every company in Orthopedic, Prosthetic & Surgical Appliances & Supplies ↗